Antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae
Report of a study group on bacterial resistance* A J HOWARD, C J HINCE, J D WILLIAMS British Medical_Journal, 1978 , 1, 1657 -1660 Summary and conclusions Twenty laboratories in England and Scotland took part in 1977 in a survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae. In Str pneumoniae 59 (6 8%) of the 866 strains studied were resistant to tetracycline and three to chloramphenicol, and one strain showed a decreased susceptibility to penicillin. The prevalence-of resistance to tetracycline was lower than that found in a similar study performed in 1975. Nine hundred and fifty-two strains of H influenzae were examined: 15 (16%) were resistant to ampicillin (all were beta-lactamase producers) and 26 (2-7%) to tetracycline. Only two strains were resistant to chloramphenicol and two to trimethoprim. Sixty-three H Introduction Both Streptococcus pneumoniae and Haemophilus influenzae are among the more antibiotic susceptible of bacterial species, but resistance in both to all the commonly used antibiotics in respiratory infections has now been described. In Str pneumoniae, for example, sulphonamide resistance was described at an early date by Ross.' Tetracycline resistance was described in 19632; penicillin,3 erythromycin, and lincomycin4 resistance in 1967; and chloramphenicol resistance in 1970. 6 Tetracycline-For analysis strains were considered to be resistant if susceptibility testing at LHMC showed them to need over 2 mg/l of tetracycline for inhibition. Altogether 866 isolates were examined and table I illustrates the prevalence of tetracycline resistance in strains from the various centres. The overall prevalence was 68 %. The MICs of tetracycline for the resistant strains ranged from 4 mg/l to 64 mg/l. In the previous survey in 1975'5 the overall prevalence of tetracycline resistance was 13 %0-a significantly higher level of resistance than found in the present study (Z2=1925; P <00005).
The reduction in the prevalence of resistance was reflected in the fact that in nearly all centres the resistance rate was lower in the present survey than in the former one. The results from different centres varied, low rates of resistance being found in Aberdeen (3-3 ), Birmingham (2 7 0°), Bristol (2 3",,), Edinburgh (0 %), and Plymouth (3 2%) and higher rates recorded for Ayr (12 3 %), Glasgow (142 "t), and the London Hospital (9-2°',). Two laboratories, University College Hospital and Inverness, did not send their isolates to LHMC but only the results of their routine sensitivity testing of Str pneumoniae to tetracycline. The reported incidence of resistance in these laboratories was 133 % (18 out Trimethoprim   525  240  88  10  5  2  2  2   Sulphamethoxazole   162  183  173  123  101  63  69 however, could be shown to produce a i-lactamase by our screening procedure. All other strains received were inhibited by 0-5 mg/l of ampicillin or less. There was little geographical variation in resistance, the rate varying from 0 0 in eight centres to only 40/ in two. Tetracycline-Organisms tested at LHMC which were inhibited by 2 mg/l of drug or more were considered to be resistant. The overall incidence was 2 7 ( ' (table I) . 'I he MICs of tetracycline for the resistant strains ranged from 4 mgil to 32 mg/l.
Chloramphenicol-Only two strains resistant to this agent were received, each requiring 8 mg/l of chloramphenicol for inhibition (sensitive strains were inhibited by 1 mg/l or less). Both were also resistant to tetracycline and neither was capsulated. Using the method described by Manten et al,19 both of the chloramphenicol-resistant strains could be shown to inactivate the drug in vitro.
Trimethoprim-Resistance to this agent was also found to be tare and to be present in only two of the strains received at LHMC (MICs of trimethoprim for these two organisms were equal to or greater than 32 mg/l). Both strains also showed decreased susceptibility to ampicillin (MICs of 2 mg/l), though neither could be shown to produce a 3-lactamase.
Sulphamethoxazole-The results provided by disc testing at LHMC for this agent were found to be inconsistent and to correlate poorly with the results of MIC testing. The MICs of sulphamethoxazole were therefore determined for many of the strains. The results are presented in table II together with the corresponding MICs of trimethoprim.
Sixty-nine out of 874 strains (79 %/) required 32 mg/l or more of sulphamethoxazole for inhibition. But repeating the sulphamethoxazole MICs of these more resistant strains with the lower inoculum of 101 colony-forming units showed that all but seven were inhibited by 16 mg/l or less of drug and of these seven strains, none required more than 64 mg/l for inhibition.
SEROTYPES OF H INFLUENZAE
Sixty-three capsulated strains were received. The serotypes comprised 3 type a, 34 type b, 6 type d, 16 type e, and 4 type f strains. Table III shows that resistance to antibiotics, in particular to ampicillin, was more common in strains of Pittman type b than in other serotypes or in non-typable strains (Z2 = 16-01; P < 0 0005). 
Discussion
In the survey carried out in 197515 the analyses were performed using the results of each laboratory's routine antibiotic susceptibility testing. For this present study it was thought that greater uniformity would be achieved, particularly in testing H influenzae, if all the results were confirmed by one laboratory. Thus, except when otherwise indicated, all the results discussed in this paper refer to results obtained at LHMC.
It might be argued that the apparent fall in tetracycline resistance in Str pneumoniae since 1975 simply reflects differences in methods between the two studies. The results of each laboratory's routine antimicrobial susceptibility testing were, however, again available for analysis in this study, and, for tetracycline resistance in Str pneumoniae, the overall incidence they reported The resistance of H influenzae to ampicillin and tetracycline remains similar to that reported by Cavanagh et all7 in 1975. The finding that antibiotic resistance, in particular to ampicillin, was more prevalent in type b than in other strains of H influenzae was unexpected. Only a few type b strains were isolated in the study (34), and a larger survey is needed to show how widespread resistance to ampicillin is in this serotype in the community at large. The results of previous surveys have been conflicting. In the United States two small studies by Khan et a120 and Smith21 reported resistance rates among type b strains as being 700 and 1100 respectively. But a larger study by Brotherton et Although there were variations in the incidence of tetracycline resistance in the strains of both Str pneumoniae and H influenzae received from different centres, the numbers received from each were too low to assess whether these results represented true geographical variations. The MICs of sulphamethoxazole for H influenzae agreed well with those of previous studies,2'25 which had used low inocula for testing, and little increase seems to have occurred in resistance to the sulphonamides. The difficulties experienced in sulphamethoxazole disc sensitivity testing were emphasised by the finding that the overall incidence of sulphonamide resistance reported by sending laboratories was around 20°. For sulphonamides the results of in-vitro testing correlate better with in-vivo results if low inocula are used,'6 and routine disc sensitivity testing seems to overestimate sulphonamide resistance in this species.
Our results indicate that ampicillin and tetracycline still retain their usefulness in the management of respiratory tract infections. But the possibility that ampicillin resistance may be more common among type b strains of H influenzae suggests that this agent is unsuitable as first-line treatment for severe haemophilus infections in children before sensitivities are known. In the present study 14 strains of H influenzae were received from blood cultures or cerebrospinal fluid and two were ampicillin resistant. Perhaps it would be judicious to start treatment of type b H influenzae infections with chloramphenicol.
